MV Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

MV Capital Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.18K	Hold	4	–	–	﹤0.01%	882
2026 Q1	$1.11K	Sell	4 -1	-20%	-$288	﹤0.01%	847
2025 Q4	$1.51K	Hold	5	–	–	﹤0.01%	757
2025 Q3	$1.4K	Buy	5 +3	+150%	+$816	﹤0.01%	747
2025 Q2	$483	Sell	2 -16	-89%	-$3.78K	﹤0.01%	852
2025 Q1	$4.38K	Buy	18 +4	+29%	+$1.2K	﹤0.01%	631
2024 Q4	$4.6K	Hold	14	–	–	﹤0.01%	616
2024 Q3	$4.68K	Buy	14 +3	+27%	+$953	﹤0.01%	634
2024 Q2	$3K	Sell	11 -17	-61%	-$4.94K	﹤0.01%	635
2024 Q1	$9.69K	Sell	28 -2	-7%	-$658	﹤0.01%	527
2023 Q4	$9.69K	Buy	30 +9	+43%	+$2.82K	﹤0.01%	524
2023 Q3	$7.53K	Sell	21 -6	-22%	-$2.31K	﹤0.01%	544
2023 Q2	$10.2K	Buy	27 +7	+35%	+$2.85K	﹤0.01%	507
2023 Q1	$9.58K	Buy	20 +1	+5%	+$468	﹤0.01%	517
2022 Q4	$7.99K	Buy	19 +12	+171%	+$4.84K	﹤0.01%	496
2022 Q3	$3K	Buy	7 +1	+17%	+$499	﹤0.01%	582
2022 Q2	$3K	Sell	6 -1	-14%	-$521	﹤0.01%	595
2022 Q1	$4K	Sell	7 -2	-22%	-$1.21K	﹤0.01%	606
2021 Q4	$7K	Buy	9 +6	+200%	+$4.49K	﹤0.01%	523
2021 Q3	$2K	Hold	3	–	–	﹤0.01%	665
2021 Q2	$2K	Buy	+3	New	+$1.83K	﹤0.01%	615

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

MV Capital Management's BIO Position: Q2 2026 in Review

MV Capital Management held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2026 at 4 shares worth $1.18K. The position accounts for ﹤0.01% of the portfolio, ranked #882.

MV Capital Management first reported a position in BIO in Q2 2021 and has held it in 21 quarters since. The position peaked at $10.2K in Q2 2023. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

MV Capital Management held 4 shares of Bio-Rad Laboratories Class A worth $1.18K as of Q2 2026.
MV Capital Management left its Bio-Rad Laboratories Class A share count unchanged in Q2 2026.
Bio-Rad Laboratories Class A made up ﹤0.01% of MV Capital Management's portfolio in Q2 2026, its #882 holding.
MV Capital Management first reported a position in Bio-Rad Laboratories Class A in Q2 2021 and has held it in 21 quarters since.
MV Capital Management's Bio-Rad Laboratories Class A position peaked at $10.2K in Q2 2023.
399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on MV Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.